References
- Coombs RRA, Mourant AE, Race RR. In-vivo isosensitisation of red cells in babies with haemolytic disease. Lancet 1946;i:264-6.
- Levine P, Backer M, Wigod M, Ponder R. A new human hereditary blood property (cellano) present in 99.8% of all bloods. Science 1949; 109:464-6.
- Daniels G. Human blood groups. 2nd ed. Oxford: Blackwell Science Ltd., 2002.
- Lewis M, Anstee DJ, Bird GWG, et al. Blood group terminology 1990. ISBT working party on terminology for red cell surface antigens. Vox Sang 1990; 58:152-69.
- Hughes-Jones NC, Gardner B. The Kell system: Studies with radiolabeled anti-K. Vox Sang 1971; 21:154-8.
- Masouredis SP, Sudora E, Mohan LC, Victoria EJ. Immunoelectron microscopy of Kell and Cellano antigens on red cell ghosts. Haematologia 1980; 13:59-64.
- Race RR, Sanger R. Blood groups in man. 6th ed. Oxford, England: Blackwell Scientific Publications, 1975.
- Reid ME, Lomas-Francis C. Blood group antigen factsbook. 2nd ed. San Diego:Academic Press, 2003.
- Lee S. Molecular basis of Kell blood group phenotypes. Vox Sang 1997;73:1-11.
- Lee S, Wu X, Son S, et al. Point mutations characterize KEL10, the KEL3, KEL4, and KEL2l alleles, and the KEL17 and KEL11 alleles. Transfusion 1996;36:490-4.
- Lee S,Wu X, Reid ME, et al. Molecular basis of the Kell (KI) phenotype. Blood 1995;85:912-6.
- Lee S,Wu X, Reid ME, Redman C. Molecular basis of the K:6,-7 [Js(a+b-)] phenotype in the Kell blood group system. Transfusion 1995;35:822-5.
- Branch DR, Muensch HA, Sy Siok Hian AL, Petz LD. Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Br J Haematol 1983;54:573-8.
- Yazdanbakhsh K, Lee S,Yu Q, Reid ME. Identification of a defect in the intracellular trafficking of a Kell blood group variant. Blood 1999;94:310-8.
- Allen FH, Jr, Lewis SJ, Fudenberg H. Studies of anti- Kpb, a new antibody in the Kell blood group system. Vox Sang 1958;3:1-13.
- Allen FH, Lewis SJ. Kpa (Penney), a new antigen in the Kell blood group system. Vox Sang 1957;2:81-7.
- Øyen R, Halverson GR, Reid ME. Review: conditions causing weak expression of Kell system antigens. Immunohematology 1997;13:75-9.
- Anstee DJ. Blood group-active surface molecules of the human red blood cell. Vox Sang 1990;58:1-20.
- Øyen R, Powell VI, Reid ME, et al. The first non- CGD McLeod phenotype male to make anti-Kx: definition of the molecular basis (abstract). Transfusion l999;39(suppl l):9OS.
- Southcott MJG, Tanner MJ, Anstee DJ. The expression of human blood group antigens during erythropoiesis in a cell culture system. Blood 1999;93:4425-35.
- Vaughan JI, Warwick R, Letsky E, et al. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
- Daniels G, Hadley A, Green GA. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003;43:115-6.
- Grant SR, Kilby MD, Meer L, et al. The outcome of pregnancy in Kell a⊓oimmunisation. BJOG 2000; 107:481-5.
- Wagner T, Resch B, Reiterer Ę Gassner C. Pancytopenia due to suppressed hematopoiesis in a case of fatal HDN due to anti-Kl and necessity of molecular KI typing (abstract). Transfusion 2002; 42(suppl):43S-44S.
- Dhodapkar KM, Blei F. Treatment of hemolytic disease of the newborn caused by anti-Kell antibody with recombinant erythropoietin. J Pediatr Hematol Oncol 2001;23:69-70.
- Wagner T, Lanzer G, Geissler K. Kell expression on myeloid progenitor cells. Leuk Lymphoma 2002; 43:479-85.
- Lee S, Zambas ED, Marsh WL, Redman CM. Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 1991;88:6353-7.
- Advani H, Zamor J, Judd WJ, et al. Inactivation of Kell blood group antigens by 2-aminoethylisothio- uronium bromide. Br J Haematol 1982;51:107-15.
- Marsh WL, Redman CM. The Kell blood group system: a review. Transfusion l99O;30:158-67.
- Lee S, Debnath AK, Redman CM. Active amino acids of the Kell blood group protein and model of the ectodomain based on the structure of neutral endopeptidase 24.11. Blood 2003;102:3028-34.
- Cartron JP, Bailly P, Le Van Kim C, et al. Insights into the structure and function of membrane polypeptides carrying blood group antigens. Vox Sang l998;74(suppl 2):29-64.
- Lee S, Zambas ED, Marsh WL, Redman CM. The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 1993;81:2804-9.
- Lee S, Zambas E, Green ED, Redman C. Organization of the gene encoding the human Kell blood group protein. Blood 1995;85:1364-70.
- Lee S, Russo DCW, Reiner AP, et al. Molecular defects underlying the Kell null phenotype. J Biol Chem 2001;276:27281-9.
- Yu LC,Twu YC, Chang CY, Lin M. Molecular basis of the Kell-null phenotype: a mutation at the splice site of human KEL gene abolishes the expression of Kell blood group antigens. J Biol Chem 2001; 276:10247-52.
- Lee S, Russo DCW, Reid ME, Redman CM. Mutations that diminish expression of Kell surface protein and lead to the Kellmod red cell phenotype. Transfusion 2003;43:1121-5.
- Bertelson CJ, Pogo AO, Chaudhuri A, et al. Localization of the McLeod locus (XK) within Xp2l by deletion analysis. Am J Hum Genet 1988; 42:703-11.
- Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001;50:755-64.
- Russo DC, Øyen R, Powell VI, et al. First example of anti-Kx in a person with McLeod phenotype and without chronic granulomatous disease. Transfusion 2OOO;40:1371-5.
- Russo DCW Lee S, Reid ME, Redman CM. Point mutations causing the McLeod phenotype. Transfusion 2002;42:287-93.
- Ho MF, Chalmers RM, Davis MB, et al. A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996;39:672-5.
- Hanaoka N, Yoshida K, Nakamura A, et al. A novel frameshift mutation in the McLeod syndrome gene in a Japanese family. J Neurol Sci 1999;165:6-9.
- Kawakami T,TakiyamaY,YoshiokaT, et al. A case of McLeod syndrome with unusually severe myopathy. J Neurol Sci 1999;166:36-9.